PMID: 1709654Jun 1, 1991Paper

Time course of moricizine's effect on signal-averaged and 12 lead electrocardiograms: insights into mechanism of action

Journal of the American College of Cardiology
M E WechslerE G Giardina


The mechanism of action of moricizine, a new antiarrhythmic agent used in the Cardiac Arrhythmia Suppression Trial, is incompletely characterized. In addition, because moricizine is extensively metabolized, plasma moricizine concentration has an unknown relation to myocardial drug effect. Signal-averaged and standard electrocardiograms (ECGs) were used to monitor moricizine's myocardial effects in 16 patients with frequent ventricular premature complexes taking 600 to 900 mg daily. Three signal-averaged ECG variables were measured: total filtered QRS duration (fQRS), root-mean-square voltage in the terminal 40 ms of the QRS complex (V40) and the terminal low amplitude duration less than 40 microV (LAS). At steady state, plasma samples were collected and serial recordings of signal-averaged and standard ECGs were taken at 0, 1, 2, 4, 6 and 8 h after moricizine administration. A 24 h ambulatory ECG was recorded throughout the test period. Moricizine prolonged the fQRS (p less than 0.05) and decreased the V40 (p less than 0.05) of the signal-averaged ECG and prolonged the QRS (p less than 0.05) and corrected JT (JTc) intervals (p less than 0.05) of the standard ECG. The time course of the signal-averaged and standard ECG variables...Continue Reading


Apr 1, 1978·The American Journal of Cardiology·E J BerbariR Lazzara
Sep 1, 1978·The American Journal of Cardiology·M E JosephsonA M Greenspan
Sep 15, 1977·European Journal of Pharmacology·P DaniloB F Hoffman
Feb 20, 1990·The American Journal of Cardiology·J T Bigger
Apr 1, 1990·Journal of the American College of Cardiology·E G Giardina, M E Wechsler
Feb 20, 1990·The American Journal of Cardiology·J T Bigger
Feb 20, 1990·The American Journal of Cardiology·L A SiddowayR L Woosley
Jul 1, 1985·The American Journal of Cardiology·D C Harrison
Apr 15, 1986·The American Journal of Cardiology·K GearR Serokman
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Mar 1, 1989·The American Journal of Cardiology·J S Steinberg, J T Bigger
Jan 1, 1987·European Journal of Clinical Pharmacology·D L HowrieL W Dittert
Oct 16, 1987·The American Journal of Cardiology·L V RosenshtraukhN A Burnashev
Oct 16, 1987·The American Journal of Cardiology·R L WoosleyR L Williams
Oct 16, 1987·The American Journal of Cardiology·J MorganrothD T Mason
Oct 16, 1987·The American Journal of Cardiology·C R WyndhamM E Josephson
Apr 1, 1985·American Heart Journal·M ZimmermannJ Richez
Apr 1, 1981·Journal of Pharmaceutical Sciences·C C WhitneyJ C Gaylord
Dec 1, 1981·The American Journal of Cardiology·H J DuffR L Woosley

❮ Previous
Next ❯


Jul 1, 1994·Journal of Clinical Pharmacology·E G GiardinaR Sciacca
Apr 1, 1995·Journal of the American College of Cardiology·A M GillisH J Duff
Nov 1, 1992·Pacing and Clinical Electrophysiology : PACE·S M DaileyV J Plumb
Mar 1, 1994·Pacing and Clinical Electrophysiology : PACE·A J Camm, L Fei

❮ Previous
Next ❯

Related Concepts

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.